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SUMMARY. Cefuroxime axetil (CA) immediate release (IR) tablets were developed and optimized by di-
rect compression method. Ten formulations were designed and optimized using central composite design
with two main variables, microcrystalline cellulose PH 102 and croscarmellose. Pharmaceutical evaluation
of the formulations was conducted emphasizing on dissolution profile of the drug by USP dissolution test
using apparatus II in 0.07 N HCl and in medium of pH 1.2, 4.5 and 6.8 to determine the dissolution pat-
tern of the low soluble drug. Test formulations were compared against reference brand using f2 similarity
factor. Test formulations were assayed by a validated HPLC method, with acetonitrile and 10 mM ammo-
nium acetate solution (pH = 5.2) in a ratio of 15:85 as mobile phase. Stability studies under stress were
conducted on selected formulations according to ICH guidelines. It was conclusive that stable CA formula-
tions could be developed by direct compression method.
